Finding solutions for some of the health problems that we face will require a new approach. For endemic conditions, such as HIV/AIDS, tuberculosis and malaria, there needs to be a way of incentivizing major pharmaceutical companies to find affordable treatments for people on a low income. As chronic and non-communicable disease rates continue to climb, governments, private sector, and non-governmental organizations are wrestling with how to provide, disseminate, and pay for adequate prevention and treatment.
The general agreement is that the old model of delivery is not sustainable in the developed countries and does not provide broad enough access in the less developed world. Emerging markets could play a key role in the solution as a source of innovation arising from the availability of talent and cost structures.
The objectives of this dialogue held under the auspices of the World Economic Forum are to better understand the role of the private sector in healthcare delivery, identify new innovative cost effective models of quality healthcare delivery and generate greater awareness of the identified scalable and replicable models across markets.
Finding solutions for some of the health problems that we face will require a new approach. For endemic conditions, such as HIV/AIDS, tuberculosis and malaria, there needs to be a way of incentivizing major pharmaceutical companies to find affordable treatments for people on a low income.
